J Marek

5.5k total citations · 1 hit paper
170 papers, 3.2k citations indexed

About

J Marek is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, J Marek has authored 170 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Endocrinology, Diabetes and Metabolism, 51 papers in Surgery and 32 papers in Epidemiology. Recurrent topics in J Marek's work include Pituitary Gland Disorders and Treatments (62 papers), Growth Hormone and Insulin-like Growth Factors (45 papers) and Adrenal and Paraganglionic Tumors (26 papers). J Marek is often cited by papers focused on Pituitary Gland Disorders and Treatments (62 papers), Growth Hormone and Insulin-like Growth Factors (45 papers) and Adrenal and Paraganglionic Tumors (26 papers). J Marek collaborates with scholars based in Czechia, United Kingdom and United States. J Marek's co-authors include Michal Kršek, Václav Hána, Jana Ježková, Vladimı́r Weiss, Roman Liščák, Z Lacinová, Vilibald Vladyka, V Justová, M Rosická and Annamaria Colao and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

J Marek

162 papers receiving 3.1k citations

Hit Papers

Guidelines of the Pituita... 2006 2026 2012 2019 2006 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
J Marek 2.0k 1.0k 909 413 368 170 3.2k
Jörgen Lindholm 2.8k 1.4× 1.0k 1.0× 337 0.4× 167 0.4× 313 0.9× 90 3.5k
Maura Arosio 4.7k 2.4× 2.1k 2.1× 832 0.9× 267 0.6× 364 1.0× 214 6.0k
Pejman Cohan 2.5k 1.3× 1.2k 1.2× 968 1.1× 116 0.3× 201 0.5× 51 3.5k
Roger Abs 4.5k 2.3× 1.6k 1.5× 793 0.9× 398 1.0× 377 1.0× 98 5.3k
Pamela U. Freda 4.7k 2.4× 1.9k 1.9× 1.3k 1.4× 180 0.4× 697 1.9× 103 5.7k
Omar Serri 1.9k 1.0× 797 0.8× 514 0.6× 161 0.4× 246 0.7× 81 2.5k
Joan Soler 894 0.5× 1.1k 1.1× 638 0.7× 182 0.4× 122 0.3× 65 2.7k
Sabrina Corbetta 1.0k 0.5× 644 0.6× 785 0.9× 151 0.4× 103 0.3× 145 3.6k
Baha M. Arafah 2.9k 1.5× 741 0.7× 512 0.6× 118 0.3× 373 1.0× 58 3.5k
Salvatore Cannavò 2.7k 1.4× 1.1k 1.1× 701 0.8× 84 0.2× 446 1.2× 180 3.9k

Countries citing papers authored by J Marek

Since Specialization
Citations

This map shows the geographic impact of J Marek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Marek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Marek more than expected).

Fields of papers citing papers by J Marek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Marek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Marek. The network helps show where J Marek may publish in the future.

Co-authorship network of co-authors of J Marek

This figure shows the co-authorship network connecting the top 25 collaborators of J Marek. A scholar is included among the top collaborators of J Marek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Marek. J Marek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ježková, Jana, László Wenchich, Hana Hansíková, et al.. (2019). <p>The relationship of mitochondrial dysfunction and the development of insulin resistance in Cushing’s syndrome</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 1459–1471. 5 indexed citations
2.
Bonello, Béatrice, Maria Carr, Xavier Iriart, et al.. (2017). Long-term functional and myocardial assessment in patients with critical aortic valve stenosis. Archives of Cardiovascular Diseases Supplements. 9(1). 113–113. 1 indexed citations
3.
Pratesi, Giovanni, J Marek, Aaron Fargion, et al.. (2010). Endovascular Repair of a Ruptured Popliteal Artery Aneurysm Associated with Popliteal Arteriovenous Fistula. European Journal of Vascular and Endovascular Surgery. 40(5). 645–648. 12 indexed citations
4.
Marek, J, Jana Ježková, Václav Hána, et al.. (2010). Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife?. European Journal of Endocrinology. 164(2). 169–178. 35 indexed citations
5.
Sridharan, Shankar, et al.. (2010). Power Doppler three-dimensional visualisation of aortic arch interruption in fetal life. Heart. 96(15). 1190–1190. 1 indexed citations
6.
Marek, J. (2010). Lanreotide Autogel Therapy in Patients with Acromegaly –Current Role and Perspectives for the Future. touchREVIEWS in Endocrinology. 6(2). 36–36. 1 indexed citations
7.
Casanueva, Felipe F., Mark E. Molitch, Janet Schlechte, et al.. (2006). Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clinical Endocrinology. 65(2). 265–273. 533 indexed citations breakdown →
8.
Rosická, M, Michal Kršek, Martin Matoulek, et al.. (2003). Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptors levels.. Physiological Research. 61–66. 46 indexed citations
9.
Silha, Josef V., Michal Kršek, Václav Hána, et al.. (2003). Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clinical Endocrinology. 58(6). 736–742. 62 indexed citations
10.
Rosická, M, Michal Kršek, Z Jarkovská, J Marek, & V Schreiber. (2002). Ghrelin - a new endogenous growth hormone secretagogue. Physiological Research. 51(5). 435–441. 31 indexed citations
11.
Justová, V, et al.. (2001). The changes of IGF binding proteins after rhGH administration to patients totally dependent on parenteral nutrition. Growth Hormone & IGF Research. 11(6). 407–415. 4 indexed citations
13.
Hradec, J, J Král, Tomáš Janota, et al.. (1999). Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog). The American Journal of Cardiology. 83(10). 1506–1509. 57 indexed citations
14.
Štěpán, J, et al.. (1997). [Spontaneous remission of corticosteroid osteopenia after successful surgical treatment of Cushing's syndrome. A cross-sectional study].. PubMed. 136(15). 464–7. 2 indexed citations
16.
Rovenský, Jozef, et al.. (1991). Evidence for immunomodulatory properties of prolactin in selected in vitro and in vivo situations. International Journal of Immunopharmacology. 13(2-3). 267–272. 21 indexed citations
17.
Dušková, J, et al.. (1984). [Carcinoma of the hypophysis with acromegaly].. PubMed. 20(3). 170–6. 4 indexed citations
18.
Marek, J, et al.. (1978). Ten-year experience with DDAVP in treatment of diabetes insipidus.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(2). 188–94. 10 indexed citations
19.
Marek, J, et al.. (1977). Influence of single peroral dose of aminoglutethimide on the rat adrenal cortex.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 11(4). 285–97. 1 indexed citations
20.
Kohout, Jiřı́, et al.. (1977). Inhibitory effect of various cytostatics and cycloheximide on acute experimental pancreatitis in rats.. Gut. 18(11). 913–918. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026